199 related articles for article (PubMed ID: 21648286)
1. Temperature-responsive and biodegradable PVA:PVP k30:poloxamer 407 hydrogel for controlled delivery of human growth hormone (hGH).
Taheri A; Atyabi F; Dinarvnd R
J Pediatr Endocrinol Metab; 2011; 24(3-4):175-9. PubMed ID: 21648286
[TBL] [Abstract][Full Text] [Related]
2. Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes.
Kojarunchitt T; Hook S; Rizwan S; Rades T; Baldursdottir S
Int J Pharm; 2011 Apr; 408(1-2):20-6. PubMed ID: 21272624
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide.
Erfani Jabarian L; Rouini MR; Atyabi F; Foroumadi A; Nassiri SM; Dinarvand R
Eur J Pharm Sci; 2013 Jan; 48(1-2):87-96. PubMed ID: 23131800
[TBL] [Abstract][Full Text] [Related]
4. Thermosensitive micelles-hydrogel hybrid system based on poloxamer 407 for localized delivery of paclitaxel.
Ju C; Sun J; Zi P; Jin X; Zhang C
J Pharm Sci; 2013 Aug; 102(8):2707-17. PubMed ID: 23839931
[TBL] [Abstract][Full Text] [Related]
5. Chitosan in situ gelation for improved drug loading and retention in poloxamer 407 gels.
Ur-Rehman T; Tavelin S; Gröbner G
Int J Pharm; 2011 May; 409(1-2):19-29. PubMed ID: 21335076
[TBL] [Abstract][Full Text] [Related]
6. Influence of oleic acid on the rheology and in vitro release of lumiracoxib from poloxamer gels.
Moreira TS; de Sousa VP; Pierre MB
J Pharm Pharm Sci; 2010; 13(2):286-302. PubMed ID: 20816013
[TBL] [Abstract][Full Text] [Related]
7. Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation.
Radivojša M; Grabnar I; Ahlin Grabnar P
Eur J Pharm Sci; 2013 Sep; 50(1):93-101. PubMed ID: 23524253
[TBL] [Abstract][Full Text] [Related]
8. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies.
M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG
Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392
[TBL] [Abstract][Full Text] [Related]
9. Sustained delivery of human growth hormone using a polyelectrolyte complex-loaded thermosensitive polyphosphazene hydrogel.
Park MR; Chun C; Ahn SW; Ki MH; Cho CS; Song SC
J Control Release; 2010 Nov; 147(3):359-67. PubMed ID: 20713099
[TBL] [Abstract][Full Text] [Related]
10. Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels.
Mansour M; Mansour S; Mortada ND; Abd Elhady SS
Drug Dev Ind Pharm; 2008 Jul; 34(7):744-52. PubMed ID: 18612913
[TBL] [Abstract][Full Text] [Related]
11. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.
Djekic L; Krajisnik D; Martinovic M; Djordjevic D; Primorac M
Int J Pharm; 2015 Jul; 490(1-2):180-9. PubMed ID: 26002567
[TBL] [Abstract][Full Text] [Related]
12. Mucoadhesive polymeric films comprising polyvinyl alcohol, polyvinylpyrrolidone, and poloxamer 407 for pharmaceutical applications.
Vecchi CF; Cesar GB; Souza PR; Caetano W; Bruschi ML
Pharm Dev Technol; 2021 Feb; 26(2):138-149. PubMed ID: 33183099
[TBL] [Abstract][Full Text] [Related]
13. [Rheological properties of poloxamer 407 aqueous solutions].
Hu J; Chen DW; Quan DQ
Yao Xue Xue Bao; 2011 Feb; 46(2):227-31. PubMed ID: 21542295
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo studies on ocular vitamin A palmitate cationic liposomal in situ gels.
He W; Guo X; Feng M; Mao N
Int J Pharm; 2013 Dec; 458(2):305-14. PubMed ID: 24409520
[TBL] [Abstract][Full Text] [Related]
15. Poloxamer-based in situ hydrogels for controlled delivery of hydrophilic macromolecules after intramuscular injection in rats.
Zhang K; Shi X; Lin X; Yao C; Shen L; Feng Y
Drug Deliv; 2015 May; 22(3):375-82. PubMed ID: 24601854
[TBL] [Abstract][Full Text] [Related]
16. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the Mechanical and Drug-Releasing Properties of Poloxamer 407 Hydrogels with Casein.
Tundisi LL; Yang R; Borelli LPP; Alves T; Mehta M; Chaud MV; Mazzola PG; Kohane DS
Pharm Res; 2021 Mar; 38(3):515-522. PubMed ID: 33638121
[TBL] [Abstract][Full Text] [Related]
18. Effect of carrageenan on poloxamer-based in situ gel for vaginal use: Improved in vitro and in vivo sustained-release properties.
Liu Y; Zhu YY; Wei G; Lu WY
Eur J Pharm Sci; 2009 Jun; 37(3-4):306-12. PubMed ID: 19491020
[TBL] [Abstract][Full Text] [Related]
19. [Characteristics of poloxamer thermosensitive in situ gel of dexamethasone sodium phosphate].
Li XY; Zhu ZJ; Cheng AY
Yao Xue Xue Bao; 2008 Feb; 43(2):208-13. PubMed ID: 18507351
[TBL] [Abstract][Full Text] [Related]
20. Injectable and sustained delivery of human growth hormone using chemically modified Pluronic copolymer hydrogels.
Park SY; Chung HJ; Lee Y; Park TG
Biotechnol J; 2008 May; 3(5):669-75. PubMed ID: 18246570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
